Microsponge to begin drug delivery trials
This article was originally published in Clinica
Advanced Polymer Systems (US) has filed a US Investigational New Drug application to begin trials of its Microsponge system for delivering the chemotherapeutic 5-fluorouracil. The company's partner, Dermik Laboratories, will begin human safety studies in mid-1995. The treatment will be tested on actinic keratosis, a precancerous skin condition which affects around 60% of predisposed people over 40. If left untreated, it can lead to invasive skin cancer. Advanced Polymer and Dermik will co-market the product upon approval.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.